Keva Health’s digital platform leverages leading clinical research in the field of pulmonary care to improve patient’s health outcomes.
Read more:
Effects of Remote Patient Monitoring on Patients Prescribed Biologic Medications (2024)
Patient Engagement on a Remote Therapeutic Monitoring Program for Asthma (2024)
Clinically Meaningful Data from Remote Spirometry Monitoring in Asthma Management. (2022)
Remote Patient Monitoring Study Among Patients with Asthma: A Single Center Experience (2022)
Read more:
RPM Predicts Early Signs of Exacerbations in Chronic Respiratory Patients (2025)
Remote Patient Monitoring Study Among Patients With Asthma (2022)
Read more:
Remote FEV1 Monitoring in Asthma Patients: A Pilot Study (2020)
Home self-monitoring in patients with asthma using a mobile spirometry system (2020)
Impact of a digital health intervention on asthma resource utilization
(2018)
Read more:
Remote Patient Monitoring for the Detection of COPD Exacerbations (2020)
Exploring the potential benefits of digital health technology for the management of COPD (2019)
Read more:
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis (2016)
Read more:
Spirometry Utilization Among Patients with Asthma (2020)
Diagnosis and early detection of COPD using spirometry (2014)
No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.